Mylan, the maker of EpiPen, is in the news again, and not because of a crazy new price hike. This time, the issue is even more concerning: Some EpiPens may fail to activate and are being recalled.
Pretty scary stuff, considering that a dose of epinephrine administered immediately after an allergic reaction takes place can mean the difference between life and death. Plus, it’s estimated that 1 in 13 kids has a food allergy in the U.S.
According to a statement by the company, “Mylan is committed to replacing recalled devices at no cost and Mylan would like to reassure patients that there will be no additional replacement-related financial burden to them as a result of this recall.”
Melissa Willets is a writer/blogger and soon-to-be mom of 4. Find her on Facebook where she chronicles her life momming under the influence. Of yoga.